Share on LinkedInShare on LinkedIn

ARTICLE · 07 MAY 2024

Generically Speaking: A Hatch-Waxman Litigation Bulletin

This quarterly issue of the GENERICally Speaking campaign provides you and your company with some of the knowledge beneficial to remaining attentive to the complexity of ANDA patent litigation.

United StatesLitigation, Mediation & Arbitration

This quarterly issue of the GENERICally Speaking campaign provides you and your company with some of the knowledge beneficial to remaining attentive to the complexity of ANDA patent litigation.

In this issue:

  • Endo Ventures Unlimited Co. v. Nexus Pharms. Inc.
    ephedrine sulfate
    Motion to dismiss for lack of personal jurisdiction granted when Defendant's principal place of business and state of incorporation were not in the forum state and its intentions to open and use a facility in the forum state could not form a basis for the Court to exercise specific personal jurisdiction over Defendant.
  • Mallinckrodt plc v. Airgas Therapeutics LLC
    INOmax® (nitric oxide)
    The court found that plaintiffs had not met their burden of pleading that French defendant purposefully directed its activities at the United States, and as a result, the court did not have personal jurisdiction.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from